Pharmacel® 101
Microcrystalline Cellulose 101

Specifications
Density | Tapped density | 440 g/l |
Bulk density | 280 g/l | |
Particle size | D10 | 25 μm |
D50 | 60 μm | |
D90 | 120 μm | |
Hausner ratio | 1,57 | |
Production site |
Nagpur, Cuddalore, India | |
Conforms to USP-NF, Ph.Eur., JP, IP |
Expected delivery within 5-7 days. Each order ships with Certificate of Analysis, Material Safety Data Sheet and Product Data Sheet.
Fast delivery
Halal and kosher certificates
Best Pharmaceutical grade lactose
Small quantities
Additional information
Consistency
Pharmacel® is industry leading with high batch-to-batch consistency on functional properties allowing you low risk during production and in your formulation development.
Pharmacel® and lactose formulations
DFE Pharma is the only global excipient manufacturer offering it’s customers both lactose and microcrystalline cellulose products for development of pharmaceutical formulations. Combination of Pharmacel® with one of the lactose grades offered by DFE Pharma provides additional benefit to formulations, by achieving the perfect combination of brittle and plastic excipient behavior.
Wet granulation
Pharmacel® 101 microcrystalline cellulose (MCC) has been developed specifically as a key component for wet granulation formulations. Using Pharmacel® 101 ensures even distribution of the granulating fluid, which in turn means uniform granulation and drying processes. Wet granulation with Pharmacel® 101 is a reliable, easily repeatable and robust process. Tablets made using Pharmacel® 101 show excellent compaction and disintegration properties.
Dry granulation
Pharmacel® 101 microcrystalline cellulose (MCC) is also an ideal excipient for use in dry granulated formulations. Ribbons do not stick to the compaction rolls during roller compaction and dry granulation can be used in formulations with a high drug dosage. For dry granulation Pharmacel® 101 opens up vital production synergies. Used with a brittle excipient, such as SuperTab® 21AN anhydrous lactose, the result is an ideal combination of high tablet strength and insensitivity to re-compaction, leading to outstandingly robust dry granulation formulations.
Document Overview
Because our PDF QAR documents are technically certified, you may experience difficulties when opening them in a browser. Save the PDF file first and then open the PDF file in a standard PDF reader (e.g. Adobe Reader)
Show all description
Show description Hide description
Show description Hide description
Show description Hide description
Show description Hide description
Show description Hide description
Show description Hide description
Show description Hide description
Show description Hide description
Show description Hide description
Show description Hide description
Show description Hide description
Show description Hide description
Show description Hide description
Show description Hide description
Show description Hide description
Show description Hide description
Show description Hide description
Show description Hide description
Show description Hide description
Show description Hide description
Show description Hide description
Show description Hide description
Show description Hide description
Show description Hide description
Show description Hide description
Show description Hide description